Clik here to view.
Orthocell, J&J’s DePuy Synthes ink R&D deal for stem cell treatment
Orthocell (ASX:OCC) said today that it landed a research collaboration deal with Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes for its Ortho-ATI stem cell regenerative therapy. The 2 groups...
View ArticleClik here to view.
Bracco Diagnostics wins another FDA nod for Lumason microspheres
Bracco Imaging U.S. subsidiary Bracco Diagnostics said today that it won FDA approval for its Lumason microsphere contrast agent to be used in ultrasonography of the urinary tract in pediatric patients...
View ArticleClik here to view.
Zimmer Biomet to pay feds another $30m in foreign bribery case
Zimmer Biomet (NYSE:ZBH) agreed to pay another $30 million to settle a foreign bribery case with the U.S. Justice Dept. and the Securities & Exchange Commission, after a 1st $22 million settlement...
View ArticleClik here to view.
Senate reintroduces bill to repeal medical device tax
A bipartisan group of senators reintroduced the Medical Device Access and Innovation Protection Act today, which would do away entirely with the 2.3% excise tax on medical devices. The move comes as...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for January 12, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
CVS to sell cheaper, generic version of Impax’s allergy injection
CVS Health Corp. (NYSE:CVS) said today that it will start selling a generic version of Impax Laboratories‘ (NSDQ:IPXL) emergency allergy injection, Adrenaclick. The device is similar to Mylan‘s...
View ArticleClik here to view.
Johnson & Johnson recalls DePuy Synthes elbow component
Johnson & Johnson (NYSE:JNJ) is recalling its DePuy Synthes radial head prosthesis because of the risk of loosening in the component that anchors the implant in the arm’s radius bone. The entire...
View ArticleClik here to view.
Dexcom surges on Medicare nod for continuous glucose monitors
DexCom (NSDQ:DXCM) said yesterday that the Centers for Medicare & Medicaid classified therapeutic continuous glucose monitors as durable medical equipment under Medicare Part B. The company’s...
View ArticleClik here to view.
Baxter to pay $18m to settle moldy IV plant case
Baxter (NYSE:BAX) agreed to pay $18 million to settle criminal and civil cases stemming from a North Carolina sterile intravenous solution plant where mold was found in air filters. The agreement...
View ArticleClik here to view.
Nordisk takes a hit from Trump, lawsuit
Novo Nordisk (NYSE:NVO) shares fell more than 5% yesterday, following comments from the President-elect regarding drug prices and a lawsuit alleging that the Danish diabetes giant made misleading...
View ArticleClik here to view.
HHS nominee Price to deal healthcare stocks, including ZBH
President-elect Donald Trump’s pick for secretary of Health and Human Services, Dr. Thomas Price, said yesterday that he will sell his individual stock holdings if he is confirmed as a member of the...
View ArticleClik here to view.
OtoNexus raises $8m for middle-ear infection tech
OtoNexus Medical Technologies raised $7.9 million to fund development of its ultrasound device used to diagnose middle-ear infections in children and determine if antibiotics are needed for treatment....
View ArticleClik here to view.
Fujifilm pulls older duodenoscopes after superbug outbreaks
Fujifilm Holdings (TSE:4901) said today that it will pull its legacy 250/450 duodenoscope models from clinical use and replace those devices with the ED-530XT model at no cost to its customers. The...
View ArticleClik here to view.
Sunshine Heart tumbles on 1-30 reverse split
Shares in Sunshine Heart (NSDQ:SSH) fell slightly today after it announced a 1-for-30 reverse split of its common stock. The company’s common stock will continue to trade under the same symbol on the...
View ArticleClik here to view.
Judge blocks dialysis aid rule
(Reuters) – A U.S. judge on Thursday put on hold a new federal rule that dialysis providers have said would prevent dialysis patients from using charitable assistance to buy private health insurance....
View ArticleClik here to view.
Medtech sits on the sidelines as ACA repeal looms
[Image by John Snape – Own work, CC BY-SA 3.0]Some major medical device industry lobbying groups are staying mum for now about the expected repeal of the U.S. Affordable Care Act—even though an...
View ArticleClik here to view.
Abbott launches St. Jude Medical’s Ensite Precision cardiac mapping
Abbott (NYSE:ABT) yesterday said it launched the EnSite Precision cardiac mapping system it acquired when it paid $25 billion for St. Jude Medical earlier this month. The commercial launch also...
View ArticleClik here to view.
VisionCare launches new clinical trial for telescope implant
VisionCare, Inc. said this week that the FDA approved its investigational device exemption for a new clinical trial in the U.S. evaluating its telescope implant in patients with end-stage macular...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for January 13, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Obalon logs 1st commercial use of weight loss balloon
Obalon Therapeutics (NSDQ:OBLN) said that it has begun U.S. commercial shipments of its Obalon weight-loss balloon. In September last year, Carlsbad, Calif.-based Obalon won pre-market approval from...
View Article